| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.54▲ | 4.57▼ | 4.56▼ | 4.54▲ | 4.41▲ |
| MA10 | 4.54▲ | 4.55▲ | 4.54▲ | 4.55▲ | 4.90▼ |
| MA20 | 4.56▲ | 4.54▲ | 4.51▲ | 4.47▲ | 4.80▼ |
| MA50 | 4.56▲ | 4.51▲ | 4.63▼ | 5.12▼ | 3.76▲ |
| MA100 | 4.55▲ | 4.60▼ | 4.44▲ | 4.64▼ | 7.65▼ |
| MA200 | 4.50▲ | 4.45▲ | 4.49▲ | 3.71▲ | 25.44▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | 0.001▲ | 0.011▲ | 0.048▲ | -0.103▼ |
| RSI | 51.663▲ | 52.133▲ | 51.156▲ | 48.279▼ | 50.447▲ |
| STOCH | 80.556▲ | 50.436 | 56.667 | 43.195 | 12.871▼ |
| WILL %R | -16.667▲ | -55.000 | -55.000 | -58.233 | -84.756▼ |
| CCI | 180.674▲ | 0.701 | 4.625 | 37.658 | -59.313 |
|
Tuesday, September 09, 2025 04:54 AM
Agenus Inc. (Nasdaq: AGEN), a leader in immuno‑oncology, today announced its investigational combination botensilimab plus balstilimab (BOT/BAL) is now available to eligible patients with refractory ...
|
|
Friday, September 05, 2025 06:14 AM
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today announced that the company will participate in the H.C. Wainwright 27th Annual Global Investment Conference, taking place September 8–10, ...
|
|
Monday, August 25, 2025 11:37 PM
Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in immuno-oncology, today announced an update to its virtual Stakeholder Briefing on August 27, 2025 at 4:00 p.m. ET which introduces a new virtual ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/09/25 | 4.51 | 4.67 | 4.50 | 4.56 | 346,245 |
| 16/09/25 | 4.46 | 4.588 | 4.4115 | 4.47 | 187,446 |
| 15/09/25 | 4.49 | 4.50 | 4.3571 | 4.45 | 239,574 |
| 12/09/25 | 4.69 | 4.73 | 4.47 | 4.48 | 354,753 |
| 11/09/25 | 4.83 | 5.0616 | 4.63 | 4.74 | 277,307 |
| 10/09/25 | 5.08 | 5.2001 | 4.78 | 4.83 | 814,623 |
| 09/09/25 | 4.33 | 5.08 | 4.30 | 5.07 | 1,044,454 |
| 08/09/25 | 4.33 | 4.33 | 4.21 | 4.26 | 267,221 |
| 05/09/25 | 4.31 | 4.37 | 4.18 | 4.33 | 334,290 |
| 04/09/25 | 4.24 | 4.30 | 4.12 | 4.29 | 307,993 |
|
|
||||
|
|
||||
|
|